Differences in CEA values determined by EIA and RIA in patients with benign and malignant biliary obstructions.
暂无分享,去创建一个
[1] M. Fleisher,et al. Roche RIA and Abbott EIA carcinoembryonic antigen assays compared. , 1984, Clinical chemistry.
[2] J. Knight,et al. Interference with carcinoembryonic antigen radioimmunoassays by glycosaminoglycans, and their removal. , 1983, Clinical chemistry.
[3] R. Lamerz,et al. Immunological comparison of carcinoembryonic antigen (CEA) extracted from tumours of various organs: their use in radioimmunological CEA determinations. , 1983, British Journal of Cancer.
[4] N. Zamcheck,et al. Inhibition of specific Kupffer-cell clearance of carcinoembryonic antigen from the serum of rats with bile-duct obstruction , 1982 .
[5] E. Martin,et al. Factors controlling the circulating CEA levels in pancreatic cancer: Some clinical correlations , 1981, Cancer.
[6] B. Wahrén,et al. Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract disease. , 1979, Clinical and experimental immunology.
[7] P. Thomas,et al. The effects of triton WR1339 and asialo-fetuin on the hepatic uptake of circulating native and asialo-carcinoembryonic antigen. , 1978, The Biochemical journal.
[8] N. Zamcheck,et al. Elevated carcinoembryonic antigen levels and biliary tract obstruction. , 1975, JAMA.